News | December 22, 2008

Pediatric Patient Treated on RapidArc Radiotherapy Technology

December 22, 2008 - A Swiss cancer clinic is among the first in the world to use the newest radiotherapy technology from Varian Medical Systems, RapidArc, to treat a child patient.

A 12-year-old girl with Hodgkin's lymphoma was treated using Varian's RapidArc technique at the Istituto Oncologico della Svizzera Italiana (IOSI) in Bellinzona, southern Switzerland.

The girl received her targeted radiotherapy dose in less than two and a half minutes, using two continuous revolutions of the device while she lay on the treatment machine. The RapidArc treatment was reportedly faster than would have been possible with conventional intensity modulated radiotherapy
(IMRT) treatments, which are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

"Treating children with cancer is always challenging, but RapidArc enables us to deliver extremely precise treatments much more quickly than would have been possible previously, making it a much more comfortable experience for the patient while minimizing damage to healthy tissue," said radiation
oncologist Dr. Alessandra Franzetti-Pellanda. "Faster treatments mean there is less chance for the patient to move during delivery, which helps precision. It can also be uncomfortable lying on the couch so to be able to reduce the time of treatment while enhancing the precision is tremendously helpful." Dr. Franzetti-Pellanda worked with head medical physicist Dr. Antonella Fogliata and medical oncologist Dr. Pierluigi Brazzola to carry out the pioneering treatment.

IOSI became the first hospital in Switzerland to commence treatments using RapidArc in November. The hospital treats 700 patients a year on two Varian Clinac medical linear accelerators and RapidArc volumetric modulated arc therapy (VMAT) capability has been added to one of these machines.

For more information:

Related Content

Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
UZ Leuven Treats First European Patient on Varian Halcyon Cancer Treatment System
News | Intensity Modulated Radiation Therapy (IMRT) | October 25, 2017
Varian recently announced an 80-year-old male with head and neck cancer became the first patient in Europe to be...
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...